No Prescription |
 |
 | ||
|
Cardizem CD Generic Diltiazem |
|
| ||
No Prescription » Prescription Drugs 3 » Cardizem CD Generic Diltiazem Cardizem CD capsules contain an active ingredient called diltiazem hydrochloride. They are designed to release the active ingredient slowly so that it works over 24 hours and can be taken once a day (CD stands for "controlled delivery"). Cardizem CD capsules belong to a group of medicines called calcium channel blockers or calcium antagonists. They work by opening up blood vessels which lowers blood pressure and lets more blood and oxygen reach the heart. They do not change the amount of calcium in your blood or bones.Cardizem CD capsules are used by some people to prevent angina and by others to treat hypertension (high blood pressure).Angina is a pain or uncomfortable sensation in the chest often spreading to the arms or neck and sometimes to the shoulders and back. The pain of angina is due to a shortage of oxygen to the heart.High blood pressure can have many different causes including kidney disease hardening of the arteries and some hormone imbalances. However the vast majority of people with high blood pressure have no identifiable cause for it. If left untreated high blood pressure can lead to serious health problems such as a stroke or heart attack.How to use Cardizem OralTake this medication by mouth with or without food usually 3-4 times daily or as directed by your doctor.The dosage is based on your age medical condition body size and response to therapy. If you are older or have severe liver problems your dosage may need to be adjusted.Use this medication regularly in order to get the most benefit from it. To help you remember use it at the same time each day. It is important to continue taking this medication even if you feel well. Most people with high blood pressure do not feel sick. For the treatment of high blood pressure it may take up to two weeks before the full benefit of this drug takes effect. When used for angina this medication must be taken regularly to be effective. It should not be used to treat angina when it occurs. Use other medications (e.g. sublingual nitroglycerin) to relieve an angina attack as directed by your doctor. Consult your doctor or pharmacist for details.Do not suddenly stop taking this medication without consulting your doctor. Your condition may become worse when the drug is suddenly stopped. Your dose may need to be gradually decreased. Buy Cardizem CD Generic Diltiazem and other Prescription Drugs 3 products online at Medstore. Buy Online at Medstore - Click Here!
About Cardizem CD Generic Diltiazem: Product Type: Prescription Drugs 3 Cardizem CD ( Generic Diltiazem ) Cardizem CD (Generic Diltiazem) Generic Diltiazem 120mg 30 Tablets 120mg 90(3 x 30) Tablets 180mg 30 Tablets 180mg 90(3 x 30) Tablets 240mg 30 Tablets 240mg 90(3 x 30) Tablets Generic Diltiazem Cardizem CD
View more Prescription Drugs 3 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
